REXAHN PHARMACEUTICALS, INC. 4
4 · REXAHN PHARMACEUTICALS, INC. · Filed Jan 24, 2017
Insider Transaction Report
Form 4
Nolan Lisa
Chief Business Officer
Transactions
- Award
Restricted Stock Units
2017-01-20+65,000→ 65,000 total→ Common Stock (65,000 underlying) - Award
Stock Option (right to buy)
2017-01-20+315,000→ 315,000 totalExercise: $0.18Exp: 2027-01-20→ Common Stock (315,000 underlying)
Footnotes (3)
- [F1]One quarter of the option vests and becomes exercisable on January 20, 2018, and, thereafter, 1/36th of the remaining option vests in equal installments on the first business day of each month until fully vested.
- [F2]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F3]The restricted stock units vest in four equal annual installments on the last business day in February, beginning February 28, 2018.